Home › Degenerative Nerve Diseases
Degenerative Nerve Diseases clinical trials recruiting in the U.S.
32 studies for Degenerative Nerve Diseases are recruiting participants at sites across the United States.
Degenerative nerve diseases, or neurodegenerative diseases, are disorders that destroy cells in your nervous system. Learn about the types and treatments.
Cities with the most studies
- Philadelphia, PA6 studies
- Orlando, FL5 studies
- Tampa, FL5 studies
- Boston, MA5 studies
- Scottsdale, AZ4 studies
- San Diego, CA4 studies
- Atlanta, GA4 studies
- Baltimore, MD3 studies
- Los Angeles, CA3 studies
- Farmington Hills, MI3 studies
- Austin, TX3 studies
- West Palm Beach, FL3 studies
- Miami, FL3 studies
- Boca Raton, FL3 studies
- Denver, CO3 studies
- New York City, NY3 studies
- Dallas, TX3 studies
- Gainesville, FL3 studies
- Chicago, IL3 studies
- San Francisco, CA3 studies
By state
- Arizona4 studies
- California10 studies
- Colorado5 studies
- Connecticut4 studies
- Florida8 studies
- Georgia5 studies
- Illinois4 studies
- Kansas3 studies
- Maryland4 studies
- Massachusetts6 studies
- Michigan4 studies
- New York4 studies
- North Carolina3 studies
- Ohio4 studies
- Oregon3 studies
- Pennsylvania6 studies
- Tennessee3 studies
- Texas8 studies
- Washington4 studies
Recently updated studies
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Nov 12, 2026 · NCT06887192A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07804615A Study of LY3439539 in Participants With Alzheimer's Disease
RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Nov 4, 2026 · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Nov 4, 2026 · NCT07589595A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Oct 29, 2026 · NCT06297590An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
RecruitingPhase 1/2
6 Months · All sexes · Updated Oct 19, 2026 · NCT05757141PET Tau - Neurodegenerative Disease Imaging
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Oct 16, 2026 · NCT03143374Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Recruiting
Ages 50 and older · All sexes · Updated Oct 15, 2026 · NCT06993142The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
RecruitingObservational studyHealthy volunteers welcome
6 Weeks · All sexes · Updated Sep 29, 2026 · NCT00271622Home Exercise for Individuals With Neurodegenerative Disease
RecruitingHealthy volunteers welcome
Ages 5 to 75 · All sexes · Updated Sep 16, 2026 · NCT05443906Prenatal Education on Environmental Exposures During Pregnancy Study (PEEPS)
RecruitingHealthy volunteers welcome
Ages 18 and older · Women · Updated Sep 14, 2026 · NCT07758114Observational Pharmaco-Epidemiology Research & Analysis
RecruitingObservational studyHealthy volunteers welcome
Ages 0 and older · All sexes · Updated Sep 11, 2026 · NCT03813862Human Observatory Study
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07646782Parkinson Progression Marker Initiative Online (PPMI Online)
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05065060Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Sep 1, 2026 · NCT06016946Biofluid Research on Age-Related or Inherited Neurodegeneration
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07798700Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
RecruitingPhase 1
Ages 40 to 75 · All sexes · Updated Aug 17, 2026 · NCT06482268Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
RecruitingPhase 4Healthy volunteers welcome
Ages 50 to 85 · All sexes · Updated Aug 7, 2026 · NCT05357612PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785Imaging Studies in Corticobasal Syndrome
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT07000851Analysis of Human ALS Tissues and Registry of ALS Patients
RecruitingObservational study
Ages 18 to 90 · All sexes · Updated Jul 8, 2026 · NCT05067179Neurologic Stem Cell Treatment Study
Recruiting
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT02795052Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
RecruitingHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Jun 10, 2026 · NCT05741853F 18 T807 Tau PET Imaging of Alzheimer's Disease
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 8, 2026 · NCT02414347Intraneural Administration of scAAV9/JeT-GAN Into the Vagus Nerve for Patients With Giant Axonal Neuropathy (GAN)
RecruitingPhase 1
Ages 10 to 25 · All sexes · Updated Apr 22, 2026 · NCT07543991From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.